Investment Rating - The report assigns a "Buy" rating to the company, maintaining the previous rating of "Buy" [1]. Core Insights - The company, Suochen Technology, is a leading domestic CAE software enterprise, deeply engaged in the defense and military sectors while continuously expanding into the civilian market. The launch of its physical AI platform is expected to empower the industrial and manufacturing sectors, creating new growth opportunities [1][5][8]. Summary by Sections Stock Performance - The company's stock has shown a year-to-date increase of 36.3%, with a 12-month performance of 47.2% [2]. Financial Projections - Revenue projections for 2025-2027 are estimated at 5.1 billion, 6.9 billion, and 9.2 billion RMB, respectively. Net profit for the same period is expected to be 0.88 billion, 1.16 billion, and 1.58 billion RMB, with EPS of 0.99, 1.30, and 1.78 RMB, respectively. The PE ratios are projected to be 72.3, 55.2, and 40.4 times [5][7]. Company Overview - Suochen Technology focuses on the research, development, and sales of CAE software, with a strong emphasis on fluid, structural, and electromagnetic algorithms. The company has established a solid reputation in the defense sector and is expanding into civilian markets, aiming to become a "Chinese Dassault" [8][16]. Market Position - The domestic CAE market is currently dominated by foreign companies, with Ansys, Siemens, and Dassault Systems holding nearly 50% of the market share. However, domestic companies are gradually increasing their market presence, with a reported 16.2% market share for domestic CAE software in 2022, up from 7% in 2016 [50][61]. Product Development - The company has developed a comprehensive product matrix, with its engineering simulation software contributing over 50% of revenue and more than 70% of gross profit from 2019 to 2024. The physical AI platform launched in March 2025 is designed to enhance simulation efficiency and accuracy, targeting commercial applications [8][26][50].

上 市 公 司 轻工制造 ——复用材料业务供应链优势，拓展机器人电子皮肤业 务，延伸成长曲线 报告原因：有信息公布需要点评 | 买入（维持） | | --- | 2025 年 06 月 30 日 天安新材 (603725) | 市场数据： | 2025 年 06 月 27 日 | | --- | --- | | 收盘价（元） | 8.55 | | 一年内最高/最低（元） | 9.31/5.32 | | 市净率 | 3.4 | | 股息率%（分红/股价） | 1.17 | | 流通 A 股市值（百万元） | 2,451 | | 上证指数/深证成指 | 3,424.23/10,378.55 | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 03 月 31 日 | | --- | --- | | 每股净资产（元） | 2.54 | | 资产负债率% | 67.93 | | 总股本/流通 A 股（百万） | 305/287 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 06-27 07-27 08-27 09-27 10-27 11-27 1 ...

2025 年 06 月 30 日 保险行业高速增长，算力领域打造新成长极 —新致软件（688590.SH）公司动态研究报告 买入(维持) 投资要点 分析师：任春阳 S1050521110006 rency@cfsc.com.cn ▌全面布局数据及智算中心建设，打造第二成长极 公司 IT 产品销售及增值服务以数据及智算中心为场景，为用 户提供建云、上云及管云一体化方案，包括网络平台、系统 平台、存储平台、算力平台等。2024 年该业务实现收入 1.07 亿元，客户主要包括金融、政务、科研院所等。公司还联合 合作伙伴华为、海光，基于华为昇腾系列芯片及海光深算系 列芯片推出 AI 一体机产品，结合自研新致新知 98B 大模型、 新致新知人工智能平台等。依托国内算力基建扩容契机，公 司前瞻性切入智能算力布局赛道，成功落地多个标杆算力集 群项目。 | 基本数据 | 2 0 2 5-0 6-2 7 | | --- | --- | | 当前股价（元） | 20.31 | | 总市值（亿元） | 53 | | 总股本（百万股） | 263 | | 流通股本（百万股） | 263 | | 52 周价格范围（元） | 9.71- ...

证券研究报告·公司点评报告·一般零售 小商品城（600415） 公司换帅董事长另有重任、公司重点战略地 位不变，自上而下持续重点支持 买入（维持） | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 11,300 | 15,737 | 21,159 | 27,307 | 33,227 | | 同比（%） | 48.30 | 39.27 | 34.45 | 29.06 | 21.68 | | 归母净利润（百万元） | 2,676 | 3,074 | 4,231 | 5,713 | 6,825 | | 同比（%） | 142.25 | 14.85 | 37.64 | 35.04 | 19.46 | | EPS-最新摊薄（元/股） | 0.49 | 0.56 | 0.77 | 1.04 | 1.24 | | P/E（现价&最新摊薄） | 40.12 | 34.93 | 25.38 | 18.79 | 15.73 | [Table_Tag ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company showcased multiple new technologies and solutions at the 28th Beijing Essen Welding and Cutting Exhibition, indicating a strong focus on innovation and market presence [7] - The company is expected to maintain rapid growth in its core laser cutting business driven by increased penetration, power upgrades, and overseas exports [7] - The company is projected to achieve significant net profit growth over the next few years, with estimates of 1.11 billion, 1.42 billion, and 1.76 billion yuan for 2025, 2026, and 2027 respectively [7] Financial Data and Profit Forecast - Total revenue is projected to grow from 1,735 million yuan in 2024 to 3,363 million yuan in 2027, with a compound annual growth rate (CAGR) of approximately 23.5% [6][8] - The net profit attributable to the parent company is expected to increase from 883 million yuan in 2024 to 1,760 million yuan in 2027, reflecting a CAGR of around 24.3% [6][8] - The company's gross margin is forecasted to remain stable around 79% over the next few years, indicating strong operational efficiency [6]

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [5]. Core Views - The company is recognized as a national-level "little giant" in heat exchangers, diversifying into the new energy sector, with production lines expected to enhance capacity in 2025 [5][9]. - The company is focusing on accelerating R&D in diversified fields, particularly in cooling systems, which are crucial for achieving national "dual carbon" goals [6][7]. - The company has established partnerships with several universities to drive innovation and maintain a competitive edge in the market [7]. Summary by Relevant Sections Market Performance - As of June 27, 2025, the closing price is 25.48 yuan, with a total market capitalization of 2,230.77 million yuan and a circulating market value of 626.32 million yuan [3]. Financial Performance - In 2024, the company achieved revenue of 347 million yuan, a year-on-year increase of 1.10%, with a net profit of 29.81 million yuan [8]. - The forecast for 2025 estimates revenue to reach 435 million yuan, reflecting a growth rate of 25.28% [8]. R&D and Product Development - The company invested 15.26 million yuan in R&D in 2024, a 9.08% increase from 2023, and holds 105 patents, including 19 invention patents [6]. - The focus areas for R&D include integrated thermal management products and new cooling systems for various applications [6][9]. Growth Drivers - The company anticipates recovery in orders from the wind power and waste heat recovery sectors, with new growth expected from energy storage, hydrogen energy, and data centers [7][9]. - The introduction of new products and partnerships with well-known clients in the energy sector is expected to drive future growth [9]. Profitability Forecast - The projected net profits for 2025-2027 are 48 million yuan, 61 million yuan, and 74 million yuan respectively, with corresponding EPS of 0.55 yuan, 0.69 yuan, and 0.85 yuan [8][9].

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [5][8]. Core Views - The company is the only solar energy platform under China Energy Conservation, focusing on photovoltaic power generation and manufacturing, with a stable operation and prioritizing efficiency [7][10]. - The company has a robust financial structure, with a debt-to-asset ratio of 52% as of the end of 2024, which is considered excellent in the industry [53]. - The company has a significant project reserve of 17GW and is actively managing its projects to optimize costs and enhance operational efficiency [50][45]. Summary by Sections Market Performance - The closing price as of June 27, 2025, is 4.38 yuan, with a market capitalization of approximately 17.16 billion yuan [3]. Financial Forecast and Valuation - The projected revenue for 2023 is 9.54 billion yuan, with a year-on-year growth rate of 3.29%. However, a decline is expected in the following years, with 2024 revenue estimated at 6.04 billion yuan, reflecting a decrease of 36.70% [6]. - The net profit attributable to the parent company is forecasted to be 1.58 billion yuan in 2023, with a projected decline in subsequent years [6][8]. Business Overview - The company operates approximately 6.08GW of photovoltaic power generation capacity and has 2.08GW under construction, with a focus on maintaining a balance between scale and efficiency [20][21]. - The photovoltaic power generation segment contributed 72% of the company's revenue in 2024, indicating its core business focus [20]. Project Management and Development - The company has locked in approximately 17GW of high-quality self-built and acquisition projects, focusing on regions with favorable solar resources and policies [50][45]. - The company is also expanding its overseas presence, particularly in emerging markets along the Belt and Road Initiative [52]. Financial Health - The company has a solid financial foundation, with a debt-to-asset ratio of 52%, which is lower than its peers, indicating effective financial management [53]. - The company has received 13.66 billion yuan in electricity subsidies, with a significant portion of its projects included in the first batch of compliant directories, reducing compliance risks [58]. Management and Governance - The company has implemented a stock option incentive plan to align the interests of management and minority shareholders, enhancing its operational dynamism [60].

Investment Rating - The report assigns a "Buy" investment rating for the company, marking its first coverage [2][7]. Core Insights - The company's performance met expectations, with a revenue of 4.443 billion yuan in 2024, reflecting a year-on-year growth of 9.47%, and a net profit of 326 million yuan, up 14.73% [4]. - In Q1 2025, the company reported a revenue of 1.042 billion yuan, a 2.76% increase year-on-year, but a net profit decline of 10.90% [4]. - The company holds nearly 50% market share in the retail blood glucose product market, with over 22 million users and partnerships with more than 4,000 distributors and nearly 600 chain pharmacies [4]. - The company is actively enhancing its online sales strategy, integrating online and offline operations to strengthen its market position [4]. - The international expansion of the Continuous Glucose Monitoring (CGM) business is accelerating, with a distribution agreement covering over 20 countries signed in November 2024 [5]. - The second-generation CGM product received Class III NMPA registration, showcasing improved accuracy and stability compared to the first generation [6]. - Revenue forecasts for 2025-2027 are projected at 4.887 billion, 5.572 billion, and 6.129 billion yuan, respectively, with corresponding EPS of 0.71, 0.94, and 1.14 yuan [7][9]. Summary by Sections Financial Performance - 2024 revenue: 4.443 billion yuan, 9.47% growth [4] - Q1 2025 revenue: 1.042 billion yuan, 2.76% growth; net profit down 10.90% [4] - 2025-2027 revenue projections: 4.887 billion, 5.572 billion, 6.129 billion yuan [7][9] Market Position - Holds nearly 50% market share in blood glucose products [4] - Over 22 million users and partnerships with 4,000+ distributors [4] - Strong online sales integration across 20+ e-commerce platforms [4] Product Development - Second-generation CGM product received Class III NMPA registration [6] - Improved accuracy with MARD value reduced to 8.71% [6] International Expansion - Distribution agreement signed for CGM products in 20+ countries [5] - FDA 510(k) application for CGM product in substantive review phase [5] Earnings Forecast - EPS projections for 2025-2027: 0.71, 0.94, 1.14 yuan [7][9] - PE ratios for 2025-2027: 30.9, 23.4, 19.2 [7][9]

Investment Rating - The report assigns a "Buy" investment rating for the company, marking the first coverage of the stock [1][6]. Core Insights - The company's performance met expectations, with a steady increase in gross margin. In 2024, the company achieved a revenue of 843 million yuan, a year-on-year decrease of 24.85%, while the net profit attributable to shareholders was 155 million yuan, down 47.74%. However, in Q1 2025, revenue rose to 265 million yuan, reflecting a year-on-year growth of 38.11%, and net profit increased by 44.11% to 72 million yuan [3][6]. - The consumables business is experiencing steady growth, driven by a multi-regional strategic layout. In 2024, consumables revenue reached 284 million yuan, a year-on-year increase of 46.22. The company is actively promoting its consumables in the U.S. market and has established a subsidiary in France to expand its presence in Europe [4][5]. - The company is deepening its focus on the respiratory health sector, with its market position continuously improving. It holds a 12.4% market share in the global home non-invasive ventilator market, ranking second, and a 30.6% share in the domestic market, ranking first among domestic brands. The company has established sales coverage in over 100 countries and regions, obtaining multiple certifications [5][6]. Financial Forecast - The company is projected to achieve revenues of 1,013 million yuan, 1,268 million yuan, and 1,610 million yuan for the years 2025, 2026, and 2027, respectively. The earnings per share (EPS) are expected to be 2.60 yuan, 3.35 yuan, and 4.47 yuan for the same years. The current stock price corresponds to price-to-earnings (PE) ratios of 30.7, 23.8, and 17.9 times for 2025, 2026, and 2027, respectively [6][9].

Investment Rating - The report assigns a "Buy" investment rating for the company, marking the first coverage of the stock [2][8]. Core Insights - The company is experiencing pressure on its performance, with a 5.79% year-on-year decline in revenue for Q1 2025, amounting to 5.927 billion yuan, and a significant drop in net profit by 69.64% to 84 million yuan [4]. - The printer business is ranked fourth globally in laser printer market share, with significant growth in the output of the BenTu laser printer business, which is leading the industry [5]. - The chip business is innovating continuously, with successful product launches in automotive electronics and industrial applications, indicating strong market recognition [6][7]. - Revenue forecasts for 2025-2027 are projected at 29.215 billion, 32.599 billion, and 36.421 billion yuan respectively, with expected EPS of 0.70, 1.05, and 1.18 yuan [8][10]. Summary by Sections Market Performance - The company's stock price is currently at 22.89 yuan, with a total market capitalization of 32.6 billion yuan and an average daily trading volume of 412.01 million yuan [2]. Business Segments - The printer segment has seen a decline in revenue, with BenTu's international printer sales dropping by 27.11% year-on-year, while the integrated circuit business also faced a 19.72% revenue decline [4]. - Despite the challenges, the overall output of chips from JiHaiWei reached 125 million units, marking a 9.38% increase year-on-year, with non-consumable chip sales growing by 38.22% [4]. Strategic Developments - The company is expanding its printer business across the entire industry chain and has made significant inroads into the信创 market, achieving a 50% year-on-year increase in output volume for 2024 [5]. - In the automotive sector, JiHaiWei has launched several innovative chips, gaining project approvals from major domestic and international car manufacturers [6]. Financial Projections - The company anticipates a gradual recovery in profitability, with net profit expected to rise to 994 million yuan in 2025, followed by 1.488 billion yuan in 2026 [10].